A systematic review and network meta ‐analysis comparing ofatumumab with other disease‐modifying therapies available in Japan for the treatment of patients with relapsing multiple sclerosis
ConclusionsThese findings, although limited by the paucity of evidence for Japanese patients, suggest that monoclonal antibody therapies (i.e. natalizumab and ofatumumab) may provide improved efficacy compared with other DMTs available in Japan for patients with RMS. (Source: Clinical and Experimental Neuroimmunology)
Source: Clinical and Experimental Neuroimmunology - July 1, 2022 Category: Neurology Authors: Christopher Drudge,
Melody Zhao,
Satoru Tanaka,
Nozomu Tanaka,
Hiromichi Otaka,
Izumi Kawachi,
Dieter A. H äring,
Róisín Brennan,
Nicholas Adlard,
Imtiaz A. Samjoo Tags: ORIGINAL ARTICLE Source Type: research
Establishing a community infusion service in Canterbury, New Zealand: strategies and lessons
J Prim Health Care. 2022 Jun;14(2):151-155. doi: 10.1071/HC21103.ABSTRACTBackground and context An increasing number of drugs and blood products need to be delivered by intravenous infusion. In the Canterbury region of New Zealand, these have historically been delivered at a hospital site; however, some infusions could be delivered in a community setting without compromising patient safety. Assessment of problem The Canterbury health system has a key strategic objective of delivering care close to patients' homes. In 2018, Canterbury district health board (DHB) put out a tender for a community infusion service that would d...
Source: Primary Care - June 30, 2022 Category: Primary Care Authors: Lisa McGonigle Brett Shand Graham McGeoch Source Type: research
Establishing a community infusion service in Canterbury, New Zealand: strategies and lessons
J Prim Health Care. 2022 Jun;14(2):151-155. doi: 10.1071/HC21103.ABSTRACTBackground and context An increasing number of drugs and blood products need to be delivered by intravenous infusion. In the Canterbury region of New Zealand, these have historically been delivered at a hospital site; however, some infusions could be delivered in a community setting without compromising patient safety. Assessment of problem The Canterbury health system has a key strategic objective of delivering care close to patients' homes. In 2018, Canterbury district health board (DHB) put out a tender for a community infusion service that would d...
Source: Journal of Primary Health Care - June 30, 2022 Category: Primary Care Authors: Lisa McGonigle Brett Shand Graham McGeoch Source Type: research
